electroCore, Inc. (ECOR)
- Previous Close
5.62 - Open
5.92 - Bid --
- Ask --
- Day's Range
5.63 - 5.92 - 52 Week Range
3.83 - 8.08 - Volume
5,710 - Avg. Volume
11,709 - Market Cap (intraday)
33.855M - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-3.42 - Earnings Date May 1, 2024 - May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
23.10
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
www.electrocore.comRecent News: ECOR
Performance Overview: ECOR
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ECOR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ECOR
Valuation Measures
Market Cap
34.76M
Enterprise Value
25.05M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.99
Price/Book (mrq)
4.67
Enterprise Value/Revenue
1.56
Enterprise Value/EBITDA
-1.37
Financial Highlights
Profitability and Income Statement
Profit Margin
-117.49%
Return on Assets (ttm)
-57.53%
Return on Equity (ttm)
-153.57%
Revenue (ttm)
16.03M
Net Income Avi to Common (ttm)
-18.83M
Diluted EPS (ttm)
-3.42
Balance Sheet and Cash Flow
Total Cash (mrq)
10.33M
Total Debt/Equity (mrq)
8.41%
Levered Free Cash Flow (ttm)
-8.68M
Research Analysis: ECOR
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: ECOR
Daily – Vickers Top Buyers & Sellers for 08/04/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Insider Picks for 02/15/2023
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 02/14/2023
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 02/13/2023
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.